Search Results
Sep 19, 2025, 12:40 ET Huawei Yenilikçi Ürün Yelpazesiyle Akıllı Teknolojinin Geleceğini Şekillendiriyor
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 12:39 ET HUAWEI представил серию смарт-часов WATCH GT 6 и другие инновационные продукты глобальном мероприятии
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 11:51 ET Huawei stellt mit bahnbrechender Produktpalette die Weichen für die Zukunft der intelligenten Technologie
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 11:51 ET Huawei trace l'avenir des technologies intelligentes avec une gamme de produits d'avant-garde
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 11:50 ET Huawei traccia il futuro della tecnologia intelligente con una gamma di prodotti pionieristici
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 11:50 ET Huawei marca el futuro de la tecnología inteligente con una línea de productos pionera
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 11:50 ET Huawei traza el futuro de la tecnología inteligente con una línea pionera de productos
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:25 ET Huawei traça o futuro da tecnologia inteligente com uma linha de produtos inovadora
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:22 ET Huawei brengt de toekomst van slimme technologie in kaart met baanbrekend productaanbod
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:19 ET Huawei určuje budoucnost inteligentních technologií novou sestavou průkopnických zařízení
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:15 ET Huawei načrtáva budúcnosť inteligentných technológií s priekopníckym produktovým radom
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:13 ET Huawei wytycza nowe kierunki rozwoju inteligentnych technologii dzięki pionierskiej linii produktów
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 10:08 ET Huawei Charts the Future of Smart Technology with Pioneering Product Lineup
https://mma.prnewswire.com/media/2777383/1bcb6044aaa31b0cd223b8dbec6c231f.jpg
More news about: HUAWEI
Sep 19, 2025, 08:30 ET TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma
maturation antigen (BCMA)-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody. This
More news about: Johnson & Johnson
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
clinical development in Q4 2025. Details of the Poster Presentations:ATG-201 (CD19 x CD3 TCE)Title: ATG-201, a Novel Steric Hindrance-based Masking CD19xCD3 T-cell Engager (TCE) for the Treatment of B Cell-related Autoimmune DiseasesAbstract Number:
More news about: Antengene Corporation Limited
Sep 19, 2025, 08:00 ET Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
enter clinical development in Q4 2025. Details of the Poster Presentations:ATG-201（CD19 x CD3 TCE）Title: ATG-201, a Novel Steric Hindrance-based Masking CD19xCD3 T-cell Engager (TCE) for the Treatment of B Cell-related Autoimmune DiseasesAbstract
More news about: Antengene Corporation Limited
Sep 19, 2025, 06:00 ET Orforgliprona, GLP-1 oral da Lilly, demonstra perda de peso significativa e melhorias cardiometabólicas nos resultados completos do ATTAIN-1, publicados no The New England Journal of Medicine
for Primary Care Providers. Clinical Diabetes 2020; 38(1):10–38. https://doi.org/10.2337/cd20-as01 [4] Não controlado para a taxa de erro tipo 1 familiar. [5] O regime de tratamento
More news about: Eli Lilly do Brasil
Sep 19, 2025, 05:30 ET Navia Markets Unveils 'Navia All-in-1 Trade & Invest' App - A Next-Gen Zero Brokerage Trading & Investing Platform
SEBI prescribed limits.Navia Markets Ltd. SEBI Registration No. INZ000095034 – NSE Member code for CM, FAO & CD: 07708 – BSE Clearing No. for CM, FAO & CD: 6341 – MCX Member ID: 45345 – NSDL DP ID: IN300378 – CDSL DP ID: 12086500 – SEBI Registration No. for DP: IN-DP-311-2017 – GST
More news about: Navia Markets Ltd.
Sep 18, 2025, 21:39 ET 2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment
therapy which uses lentivirus as a gene vector to transfect autologous T cells. The CAR contains a fully human scFv, CD8a hinge and transmembrane domain, and 4-1BB co-stimulatory molecule and CD3ζactivation domains. Based on rigorous molecular structure screening and comprehensive in vitro and in vivo functional
More news about: IASO Bio
Sep 18, 2025, 15:40 ET Orforgliprona, GLP-1 oral da Lilly, é superior à semaglutida oral em estudo head-to-head
Care Providers. Clinical Diabetes 2020; 38(1):10–38. https://doi.org/10.2337/cd20-as014 Não controlado para erro tipo 1 familiar. 5 O regime
More news about: Eli Lilly do Brasil
Sep 18, 2025, 10:22 ET Incredibuild Unveils State-of-the-Art AI Platform to Accelerate the Entire Software Development Lifecycle
increasingly spending more time reviewing and debugging AI-generated code than writing their own. Traditional pull request (PR) reviews, build, test, and CI/CD systems are reaching their limits: Toolchains are overloaded, pipelines are brittle, and feedback loops grow slow, noisy and fragmented. These bottlenecks
More news about: Incredibuild
Sep 18, 2025, 09:00 ET New Research Strengthens Evidence of Cranberry Health Benefits
Blumberg JB, Basu A, Krueger CG, Lila MA, Neto CC, Novotny JA, Reed JD, Rodriguez-Mateos A, Toner CD. Impact of Cranberries on Gut Microbiota and Cardiometabolic Health: Proceedings of the Cranberry Health Research Conference 2015. Adv Nutr. 2016 Jul
More news about: The Cranberry Institute
Sep 17, 2025, 17:09 ET MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.
delivery platform technology, HN2301 was administered intravenously without prior lymphodepletion to deliver CAR-encoding mRNA to CD8+ T cells, reprogramming them into CD19-targeted CAR T cells in vivo. "This study marks the first clinical proof-of-concept of the cell targeted-LNP based in vivo
More news about: Shenzhen MagicRNA Biotech Co., Ltd.
Sep 17, 2025, 12:30 ET Clean Elections Successfully Delivers CD 7 Debates Following Unexpected Vacancy
content:https://www.prnewswire.com/news-releases/clean-elections-successfully-delivers-cd-7-debates-following-unexpected-vacancy-302558584.html
More news about: Citizens Clean Elections Commission
Sep 17, 2025, 12:08 ET Wheeler Bio and MindImmune Therapeutics Sign CDMO Partnership Agreement to Support MindImmune's Lead Alzheimer's Prevention Program, MITI-101
Wheeler's ModularCMC platform is designed to streamline the path from discovery to clinical study initiationMITI-101 is designed to block CD11c+ immune cell recruitment from the blood into the brain and to prevent their pathologic effects in Alzheimer's disease. The mAb is a first-in-class
More news about: Wheeler Bio, Inc.